GALLERY

Credit cards not just allow us to make desired expenses even if there are temporary liquidity issues but also ensure we maximise the value of those expenses with benefits like cashback, reward points, special discounts, etc., at no extra cost if we clear our total outstanding in full on time during every billing cycle. Financial discipline while using credit cards also help their users in building their credit histories and…

The vaccination for COVID-19 is underway in the country in full swing. On Monday, the Ministry of Health and Family Welfare said that people who have to travel abroad can now take the second dose of the Covishield vaccine after 28 days. Earlier, the second dose of the Covishield vaccine was being administered after 28 days but later, it was extended to 12 weeks. The ministry has issued guidelines to…

The All India Institute of Medical Sciences (AIIMS) in Delhi plans to begin clinical trials of Bharat Biotech’s Covid-19 vaccine “Covaxin” on children, news agency ANI cited sources as saying. AIIMS Patna has been already been conducting a Paediatric clinical trial of Covaxin after Bharat Biotech gained approval from the Drugs Controller General of India (DCGI) to begin paediatric clinical studies on May 11. At AIIMS Patna, trials for children…

Google has come up with a new feature for its Phone app that will announce the name and number of any incoming calls. As per The Verge, with the new feature, a user can set whether they want the app to announce caller ID every time the phone rings, only when they are wearing a headset, or never. Currently, the Pixel phone owners in the US have received the automatic…

London: Oxford’s COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday. The vaccine candidate, which has been licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed by a full dose, compared to a two full-dose regime, though more work needs…

London:  Asymptomatic coronavirus sufferers appear to lose detectable antibodies sooner than people who have exhibited Covid-19 symptoms, according to one of the biggest studies of its kind in Britain published on Tuesday. The findings by Imperial College London and market research firm Ipsos Mori also suggest the loss of antibodies was slower in 18-24 year-olds compared to those aged 75 and over. Overall, samples from hundreds of thousands of people…

Anjana and Kusum are not the only school kids, who are forced to turn fruit seller. There are umpteen children, who are doing odd jobs to fil… Neither scorching heat nor incessant rain deters 10-year-old Anjana and seven-year-old Kusum from eking out a living by selling fruits on t… Read More 03 / 25 Read More>> Source:- indiatimes